中国骨质疏松杂志
中國骨質疏鬆雜誌
중국골질소송잡지
CHINESE JOURNAL OF OSTEOPOROSIS
2014年
5期
471-475,484
,共6页
高璐%郑洪新%尚德阳%宗志红%林庶茹
高璐%鄭洪新%尚德暘%宗誌紅%林庶茹
고로%정홍신%상덕양%종지홍%림서여
骨质疏松症%补肾中药%骨组织
骨質疏鬆癥%補腎中藥%骨組織
골질소송증%보신중약%골조직
Osteoporosis%Kidney-tonifying traditional Chinese medicine%Bone tissue
目的:研究补肾中药复方(鹿茸、牡蛎、淫羊藿)对去卵巢骨质疏松症大鼠的影响,探讨肾虚骨质疏松症的病理机制,为中医药防治骨质疏松症提供实验依据。方法采用摘除雌性大鼠双侧卵巢的方法复制骨质疏松症模型,以正常组作为标准对照,模型组作为空白对照,盖天力组作为阳性对照,补肾中药复方低、中、高剂量组作为实验组。各用药组灌胃给药12周。采用腹主动脉取血法采集大鼠血清测定血骨钙素(BGP)和抗酒石酸酸性磷酸酶(TRACP),并用DEXA骨密度仪检测左侧股骨骨密度;右侧股骨匀浆提取骨组织中的TotalRNA,RT-RealTimePCR,检测MEK1及ERK2的mRNA表达水平。结果模型组BGP水平显著低于正常组(P<0.01),TRAP水平较正常组显著升高(P<0.01);正常组和补肾中药复方组的股骨骨密度均高于模型组(P<0.05);ERK2mRNA相对表达量明显高于模型组(P<0.01),MEK1mRNA相对表达量明显低于模型组(P<0.01)。结论补肾中药复方具有防治去卵巢大鼠骨质疏松的作用,其机制与调控MEK1、ERK2基因表达有关。
目的:研究補腎中藥複方(鹿茸、牡蠣、淫羊藿)對去卵巢骨質疏鬆癥大鼠的影響,探討腎虛骨質疏鬆癥的病理機製,為中醫藥防治骨質疏鬆癥提供實驗依據。方法採用摘除雌性大鼠雙側卵巢的方法複製骨質疏鬆癥模型,以正常組作為標準對照,模型組作為空白對照,蓋天力組作為暘性對照,補腎中藥複方低、中、高劑量組作為實驗組。各用藥組灌胃給藥12週。採用腹主動脈取血法採集大鼠血清測定血骨鈣素(BGP)和抗酒石痠痠性燐痠酶(TRACP),併用DEXA骨密度儀檢測左側股骨骨密度;右側股骨勻漿提取骨組織中的TotalRNA,RT-RealTimePCR,檢測MEK1及ERK2的mRNA錶達水平。結果模型組BGP水平顯著低于正常組(P<0.01),TRAP水平較正常組顯著升高(P<0.01);正常組和補腎中藥複方組的股骨骨密度均高于模型組(P<0.05);ERK2mRNA相對錶達量明顯高于模型組(P<0.01),MEK1mRNA相對錶達量明顯低于模型組(P<0.01)。結論補腎中藥複方具有防治去卵巢大鼠骨質疏鬆的作用,其機製與調控MEK1、ERK2基因錶達有關。
목적:연구보신중약복방(록용、모려、음양곽)대거란소골질소송증대서적영향,탐토신허골질소송증적병리궤제,위중의약방치골질소송증제공실험의거。방법채용적제자성대서쌍측란소적방법복제골질소송증모형,이정상조작위표준대조,모형조작위공백대조,개천력조작위양성대조,보신중약복방저、중、고제량조작위실험조。각용약조관위급약12주。채용복주동맥취혈법채집대서혈청측정혈골개소(BGP)화항주석산산성린산매(TRACP),병용DEXA골밀도의검측좌측고골골밀도;우측고골균장제취골조직중적TotalRNA,RT-RealTimePCR,검측MEK1급ERK2적mRNA표체수평。결과모형조BGP수평현저저우정상조(P<0.01),TRAP수평교정상조현저승고(P<0.01);정상조화보신중약복방조적고골골밀도균고우모형조(P<0.05);ERK2mRNA상대표체량명현고우모형조(P<0.01),MEK1mRNA상대표체량명현저우모형조(P<0.01)。결론보신중약복방구유방치거란소대서골질소송적작용,기궤제여조공MEK1、ERK2기인표체유관。
Objective To investigate the effect of the kidney-tonifying traditional Chinese medicine ( velvet, oysters, and epimedium) on osteoporosis in ovariectomized rats, and to explore the pathogenesis of osteoporosis with kidney-deficiency, in order to provide experimental evidence for Chinese medicine in the prevention and treatment of osteoporosis. Methods The osteoporosis model was established using bilateral ovariectomy in female rats.The normal control group was set as a standard control.The model group was set as blank control.The Gaitianli group was set as a positive control.The low, medium, and high dose of traditional Chinese medicine for kidney-tonifying groups were set as experimental groups.Rats in each treatment group were gavaged for 12 weeks.Blood was collected from the abdominal aorta, and the serum levels of osteocalcin ( BGP) and tartrate-resistant acid phosphatase ( TRACP) were detected.The bone mineral density ( BMD) of the left femur was detected using DEXA. The total RNA of the right femur bone tissue homogenate was extracted and the mRNA expression levels of MEK1 and ERK2 were detected using RT-real time PCR.Results The serum BGP level in model group was significantly lower than that in the normal group (P<0.01), while the serum TRAP level increased significantly compared with that in the normal group (P<0.01).BMD of the femur in the normal group and the kidney-tonifying traditional Chinese medicine group was significantly higher than that in the model group (P<0.05).The relative expression level of ERK2 mRNA was significantly higher than that in the model group (P<0.01), while the relative expression level of MEK1 mRNA was significantly lower than that in the model group (P <0.01). Conclusion The kidney-tonifying traditional Chinese medicine plays a role in the prevention and treatment of osteoporosis in ovariectomized rats.Its mechanism may be related to the regulation of MEK1 and ERK2 gene expression.